Chinese Medicine Treatment of Adolescent Sleep Disorders & Sleeping Pills

Status Recruiting

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of traditional Chinese medicine in the treatment of adolescent sleep disorders and the effect of sleeping pills withdrawal.

Clinical Trial Description

All subjects giving written informed consent. In this multicenter,controlled, prospective cohort study, the outpatient and inpatient adolescent sleep disorder patients' baseline demographic data were collected, including age, gender, education background, and medication history. Venous blood samples were collected and sent to laboratory test for blood routine, and blood biochemistry at Baseline and Week 4. The Pittsburgh sleep quality index (PSQI) was used to assess the patients' sleep quality at baseline, month 1, month 3 and month 6. Objective sleep quality data is assessed by wearing a Sleep wearable devices. The classic Morningness-Eveningness Questionnaire and wearable devices was used to assess the patients' chronotype at baseline and week 4.Subjects who visit the TCM clinic of this project received Suanzaoren Decoction and Huanglian Wendan Decoction and other decoctions orally twice daily for 4 weeks. Add or subtract Chinese herbal medicine according to the different clinical manifestations of each patient. Subjects from TCM clinic who had previously taken Western medicine hypnotics continued taking them, and for those who had not taken before, Western medicine hypnotics shall not be given/prescribed. Subjects who visit the Western medicine clinic of this project received cognitive behavioral therapy, if for various reasons can not accept cognitive behavioral therapy, or have received cognitive behavioral therapy is not effective, according to the doctor to consider drug treatment, taking Zolpidem Tartrate Tablets 0.25mg/kg, the maximum dose was 10mg / day ; according to the doctor 's clinical consideration, anxiety and depression drugs can be added. For patients under 18 years of age, under the careful consideration of the doctor for drug treatment, taking oxazepam tablets, 3.75-15mg / day, if necessary, signed informed consent of clinical medication. Adverse reactions were closely monitored during medication.The participants will have a follow-up visit every two weeks, and the prescription would be adjusted according to the condition of illness.Cessation rate of Western medicine hypnotics was assessed at Month 6. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06244277
Study type	Interventional
Source	The First Affiliated Hospital with Nanjing Medical University
Contact	Xiuqin Wang, doctor
Phone	+86-25-68306156
Email	xiuqinw@126.com
Status	Recruiting
Phase	N/A
Start date	December 22, 2023
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05820919` - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase	N/A
Recruiting	`NCT04786314` - The Effect of Hot and Cold Water Application on Pregnant Women With Restless Leg Syndrome	N/A
Recruiting	`NCT05775731` - Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
Recruiting	`NCT03326765` - Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)	N/A
Completed	`NCT03673397` - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression	N/A
Completed	`NCT03903263` - Sleep Disturbances in Dermatology Patients
Not yet recruiting	`NCT06012513` - Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis
Not yet recruiting	`NCT05950932` - Effects of Melissa Extract on Sleep Characteristics	Phase 4
Completed	`NCT01463839` - Sleep Disorder and Oral Habits in Children	N/A
Completed	`NCT00940589` - Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor	Phase 2
Recruiting	`NCT06093633` - A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders
Completed	`NCT06108115` - Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder	N/A
Completed	`NCT05511818` - Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes	N/A
Active, not recruiting	`NCT04291014` - Light Therapy for PD - Dose Selection	N/A
Completed	`NCT04560595` - Remote Guided Caffeine Reduction	N/A
Completed	`NCT06008470` - Investigation of Respiratory Muscle Strength, Exercise Capacity, Physical Activity and Sleep Quality Level in Individuals With Covid-19 Infection
Recruiting	`NCT06129942` - Light Therapy in Parkinson's Disease	N/A
Recruiting	`NCT04318067` - Melatonin in ADHD and Sleep Problems	Phase 4
Completed	`NCT03857802` - Efficiency of a Nursing Intervention in Sleep Hygiene	N/A
Completed	`NCT03532269` - Validation of the Sleep Assessment Algorithm in the Medical Application Nightly	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Chinese Medicine Treatment of Adolescent Sleep Disorders and Sleeping Pills Withdrawal

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms